Radiographic progression with nonrising PSA in metastatic castration-resistant prostate cancer: post hoc analysis of PREVAIL

BACKGROUND: Advanced prostate cancer is a phenotypically diverse disease that evolves through multiple clinical courses. PSA level is the most widely used parameter for disease monitoring, but it has well-recognized limitations. Unlike in clinical trials, in practice, clinicians may rely on PSA moni...

Descripción completa

Detalles Bibliográficos
Autores principales: Bryce, A H, Alumkal, J J, Armstrong, A, Higano, C S, Iversen, P, Sternberg, C N, Rathkopf, D, Loriot, Y, de Bono, J, Tombal, B, Abhyankar, S, Lin, P, Krivoshik, A, Phung, D, Beer, T M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5435962/
https://www.ncbi.nlm.nih.gov/pubmed/28117385
http://dx.doi.org/10.1038/pcan.2016.71

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5435962/
https://www.ncbi.nlm.nih.gov/pubmed/28117385
http://dx.doi.org/10.1038/pcan.2016.71

Ejemplares similares